The Latest Trading Price of Pfizer Ltd is ₹ 4698 as of 05 May 15:30
. The P/E Ratio of Pfizer Ltd changed from 41.6 on March 2021 to 23.9 on March 2025 . This represents a CAGR of -10.49% over 5 yearsThe P/E Ratio of Syschem (India) Ltd changed from 33.7 on March 2023 to 332.4 on March 2025 . This represents a CAGR of 114.46% over 3 years The Market Cap of Pfizer Ltd changed from ₹ 20684 crore on March 2021 to ₹ 18317 crore on March 2025 . This represents a CAGR of -2.40% over 5 yearsThe Market Cap of Syschem (India) Ltd changed from ₹ 16.16 crore on March 2021 to ₹ 159.08 crore on March 2025 . This represents a CAGR of 57.99% over 5 years The revenue of Pfizer Ltd for the Dec '25 is ₹ 683.24 crore as compare to the Sep '25 revenue of ₹ 684.19 crore. This represent the decline of -0.14% The revenue of Syschem (India) Ltd for the Dec '25 is ₹ 141.5 crore as compare to the Sep '25 revenue of ₹ 103.61 crore. This represent the growth of 36.57% The ebitda of Pfizer Ltd for the Dec '25 is ₹ 208.2 crore as compare to the Sep '25 ebitda of ₹ 271.78 crore. This represent the decline of -23.39% The ebitda of Syschem (India) Ltd for the Dec '25 is ₹ 5.96 crore as compare to the Sep '25 ebitda of ₹ 3.31 crore. This represent the growth of 80.06% The net profit of Pfizer Ltd changed from ₹ 150.71 crore to ₹ 141.84 crore over 7 quarters. This represents a CAGR of -3.41%
The net profit of Syschem (India) Ltd changed from ₹ 0.14 crore to ₹ 4.17 crore over 7 quarters. This represents a CAGR of 595.49%
The Dividend Payout of Pfizer Ltd changed from 32.18 % on March 2021 to 98.34 % on March 2025 . This represents a CAGR of 25.03% over 5 yearsThe Dividend Payout of Syschem (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Pfizer Ltd
Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
It has its own manufacturing facility at Goa and Thane.
It has the distinction of being the first pharmaceutical company in India to start clinical research.
The Company sells products in nearly 185 countries having 43 manufacturing sites globally.
About Syschem (India) Ltd
Syschem (India) Limited, formerly known as Anil Pesticides Limited was incorporated on 31 December, 1993.
The name of the Company was changed from Anil Pesticides Limited to Syschem (India) Limited on February 17, 2003.
Company is engaged in the business of manufacturing of API / Intermediates.
It has its manufacturing facility at Village Bargodam, Tehsil Kalka, Distt.
Panchkula (Haryana).
In 1996 the company went for launching new product called Monocrotophos and production was commissioned in 1998.
The company expanded the installed capacity of Dichlorvos by 400 TPM in 2000.
The company introduced new products namely Deta,DETC and Ethion in 2001.
FAQs for the comparison of Pfizer Ltd and Syschem (India) Ltd
Which company has a larger market capitalization, Pfizer Ltd or Syschem (India) Ltd?
Market cap of Pfizer Ltd is 21,426 Cr while Market cap of Syschem (India) Ltd is 247 Cr
What are the key factors driving the stock performance of Pfizer Ltd and Syschem (India) Ltd?
The stock performance of Pfizer Ltd and Syschem (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Pfizer Ltd and Syschem (India) Ltd?
As of May 5, 2026, the Pfizer Ltd stock price is INR ₹4683.7. On the other hand, Syschem (India) Ltd stock price is INR ₹50.52.
How do dividend payouts of Pfizer Ltd and Syschem (India) Ltd compare?
To compare the dividend payouts of Pfizer Ltd and Syschem (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.